Clinical trial
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
NCT02931240 is registered in ClinicalTrials.gov with BioVentrix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
- Lead sponsor
- BioVentrix
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 29, 2017
- Completion date
- June 30, 2027
- Enrollment
- 126 (estimated)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.